Selected research
Market Structure
Global Ornidazole Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ornidazole Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ornidazole Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ornidazole Capsules include Yangtze River Pharmaceutical Group, Xi'an Wanlong Pharmaceutical Co., Ltd. and Sichuan Baili Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ornidazole Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ornidazole Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ornidazole Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ornidazole Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Ornidazole Capsules Segment by Company
Yangtze River Pharmaceutical Group
Xi'an Wanlong Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Ornidazole Capsules Segment by Type
125mg
250mg
Ornidazole Capsules Segment by Application
Hospital
Clinic
Other
Ornidazole Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ornidazole Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ornidazole Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ornidazole Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ornidazole Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ornidazole Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ornidazole Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ornidazole Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 125mg
- 250mg
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yangtze River Pharmaceutical Group
- Xi'an Wanlong Pharmaceutical Co., Ltd.
- Sichuan Baili Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ornidazole Capsules Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ornidazole Capsules Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ornidazole Capsules Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ornidazole Capsules Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ornidazole Capsules Market Dynamics
- 2.1 Ornidazole Capsules Industry Trends
- 2.2 Ornidazole Capsules Industry Drivers
- 2.3 Ornidazole Capsules Industry Opportunities and Challenges
- 2.4 Ornidazole Capsules Industry Restraints
3 Ornidazole Capsules Market by Manufacturers
- 3.1 Global Ornidazole Capsules Revenue by Manufacturers (2021-2026)
- 3.2 Global Ornidazole Capsules Sales by Manufacturers (2021-2026)
- 3.3 Global Ornidazole Capsules Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ornidazole Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ornidazole Capsules Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ornidazole Capsules Manufacturers, Product Type & Application
- 3.7 Global Ornidazole Capsules Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ornidazole Capsules Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ornidazole Capsules Players Market Share by Revenue in 2025
- 3.8.3 2025 Ornidazole Capsules Tier 1, Tier 2, and Tier 3
4 Ornidazole Capsules Market by Type
- 4.1 Ornidazole Capsules Type Introduction
- 4.1.1 125mg
- 4.1.2 250mg
- 4.2 Global Ornidazole Capsules Sales by Type
- 4.2.1 Global Ornidazole Capsules Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ornidazole Capsules Sales by Type (2021-2032)
- 4.2.3 Global Ornidazole Capsules Sales Market Share by Type (2021-2032)
- 4.3 Global Ornidazole Capsules Revenue by Type
- 4.3.1 Global Ornidazole Capsules Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ornidazole Capsules Revenue by Type (2021-2032)
- 4.3.3 Global Ornidazole Capsules Revenue Market Share by Type (2021-2032)
5 Ornidazole Capsules Market by Application
- 5.1 Ornidazole Capsules Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Ornidazole Capsules Sales by Application
- 5.2.1 Global Ornidazole Capsules Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ornidazole Capsules Sales by Application (2021-2032)
- 5.2.3 Global Ornidazole Capsules Sales Market Share by Application (2021-2032)
- 5.3 Global Ornidazole Capsules Revenue by Application
- 5.3.1 Global Ornidazole Capsules Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ornidazole Capsules Revenue by Application (2021-2032)
- 5.3.3 Global Ornidazole Capsules Revenue Market Share by Application (2021-2032)
6 Global Ornidazole Capsules Sales by Region
- 6.1 Global Ornidazole Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ornidazole Capsules Sales by Region (2021-2032)
- 6.2.1 Global Ornidazole Capsules Sales by Region (2021-2026)
- 6.2.2 Global Ornidazole Capsules Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ornidazole Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ornidazole Capsules Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ornidazole Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ornidazole Capsules Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ornidazole Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ornidazole Capsules Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ornidazole Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ornidazole Capsules Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ornidazole Capsules Revenue by Region
- 7.1 Global Ornidazole Capsules Revenue by Region
- 7.1.1 Global Ornidazole Capsules Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ornidazole Capsules Revenue by Region (2021-2026)
- 7.1.3 Global Ornidazole Capsules Revenue by Region (2027-2032)
- 7.1.4 Global Ornidazole Capsules Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ornidazole Capsules Revenue (2021-2032)
- 7.2.2 North America Ornidazole Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ornidazole Capsules Revenue (2021-2032)
- 7.3.2 Europe Ornidazole Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ornidazole Capsules Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ornidazole Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ornidazole Capsules Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ornidazole Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yangtze River Pharmaceutical Group
- 8.1.1 Yangtze River Pharmaceutical Group Company Information
- 8.1.2 Yangtze River Pharmaceutical Group Business Overview
- 8.1.3 Yangtze River Pharmaceutical Group Ornidazole Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yangtze River Pharmaceutical Group Ornidazole Capsules Product Portfolio
- 8.1.5 Yangtze River Pharmaceutical Group Recent Developments
- 8.2 Xi'an Wanlong Pharmaceutical Co., Ltd.
- 8.2.1 Xi'an Wanlong Pharmaceutical Co., Ltd. Company Information
- 8.2.2 Xi'an Wanlong Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Xi'an Wanlong Pharmaceutical Co., Ltd. Ornidazole Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Xi'an Wanlong Pharmaceutical Co., Ltd. Ornidazole Capsules Product Portfolio
- 8.2.5 Xi'an Wanlong Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Sichuan Baili Pharmaceutical Co., Ltd.
- 8.3.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Sichuan Baili Pharmaceutical Co., Ltd. Ornidazole Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sichuan Baili Pharmaceutical Co., Ltd. Ornidazole Capsules Product Portfolio
- 8.3.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ornidazole Capsules Value Chain Analysis
- 9.1.1 Ornidazole Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ornidazole Capsules Production Mode & Process
- 9.2 Ornidazole Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ornidazole Capsules Distributors
- 9.2.3 Ornidazole Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst